Why No PSA Test After 70? What the Guidelines Actually Say
Most men over 70 get told by their doctor to stop PSA testing. Some accept it. Others push back. The recommendation exists for real reasons, but it is not a blanket rule that applies to every man the same way.
Here is what the evidence actually shows, why the guideline exists, and what questions are worth asking your doctor before you decide either way.
Where Does the "No PSA After 70" Rule Come From?
The recommendation comes from major medical bodies including the US Preventive Services Task Force, Cancer Council Australia, and the Royal Australian College of General Practitioners. Their position is that routine PSA screening offers diminishing returns for men over 70 and carries real risks of harm.
The core reasoning is this. Prostate cancer is common in older men, but most of those cancers grow slowly. A man diagnosed at 72 with a low-grade tumour is statistically more likely to die from heart disease, stroke, or another condition before the prostate cancer ever becomes a problem. Treating that cancer, however, carries genuine risks including incontinence, erectile dysfunction, and complications from surgery or radiation.
What the guidelines are really saying is that the balance between benefit and harm shifts as men age. That is not the same as saying the test is useless or that cancer stops mattering.
Should a 70 Year Old Get a PSA Test?
It depends on the individual, and that answer comes with an immediate follow-up. A healthy 70-year-old man with a family history of aggressive prostate cancer, a previous elevated PSA, or symptoms that suggest prostate problems is in a very different position than a 70-year-old with multiple serious health conditions and a life expectancy under ten years.
In my experience reviewing how these conversations play out in clinical settings, the guideline gets applied too broadly. Doctors sometimes stop testing at 70 as a default without having the conversation about individual risk. That is where men get shortchanged.
The Australian guidelines do not say never test after 70. They say routine population-level screening is not recommended. A man who asks for the test, understands the tradeoffs, and has a reasonable life expectancy can still have an informed discussion with their GP about whether testing makes sense for them.
If you are 70, fit, and have a father or brother who had prostate cancer, stopping PSA testing without a conversation is not good medicine.
What Is a Normal PSA for a 76 Year Old Man?
PSA levels rise naturally with age, which is one reason age-specific reference ranges exist. For a man in his mid-seventies, a PSA under 4.0 ng/mL is generally considered within the normal range, but that number alone tells you very little.
What matters more is the trend over time. A PSA that has been sitting at 3.2 for five years is far less concerning than one that jumped from 2.1 to 4.8 in eighteen months. That rate of change, called PSA velocity, is often more informative than any single reading.
A PSA between 4 and 10 ng/mL sits in what urologists call the grey zone. At that level, roughly one in four men will have prostate cancer on biopsy. Above 10 ng/mL, the probability rises significantly. But even a PSA of 6 in a 76-year-old man does not automatically mean cancer. Benign prostatic hyperplasia, prostatitis, and even vigorous exercise can push the number up.
The test is a signal, not a diagnosis. It tells you something worth investigating, not what the answer is.
What Are the First Hints That Your Body Is Fighting Prostate Cancer?
Early prostate cancer usually produces no symptoms at all. That is the uncomfortable truth that makes screening conversations complicated. By the time symptoms appear, the cancer has often grown beyond the prostate or spread to nearby tissue.
When symptoms do show up, they tend to involve urinary changes. Difficulty starting urination, a weak or interrupted stream, needing to urinate more often at night, or a feeling that the bladder never fully empties are all worth reporting to a doctor. Blood in the urine or semen is a more urgent signal.
Pain in the lower back, hips, or pelvis that does not have an obvious cause can indicate cancer that has spread to bone. This is more common in advanced disease, but it is worth knowing.
The catch is that most of these symptoms are also caused by benign prostatic hyperplasia, which is extremely common in men over 60. Symptoms alone cannot tell you whether cancer is present. That is exactly why the PSA test, despite its limitations, remains a useful early signal when used thoughtfully.
How Serious Is Prostate Cancer in a 70 Year Old?
This is where the conversation gets more nuanced than most articles admit. Prostate cancer is not one disease. It ranges from slow-growing tumours that may never cause harm to aggressive cancers that spread quickly and kill within years.
The Gleason score, assigned after a biopsy, grades how aggressive the cancer cells look under a microscope. A Gleason 6 cancer in a 70-year-old man is often managed with active surveillance, meaning regular monitoring without immediate treatment. A Gleason 8, 9, or 10 is a different situation entirely and warrants aggressive treatment regardless of age.
What I found when looking at the survival data is that age at diagnosis matters less than most people assume. A 70-year-old man in good health has a life expectancy of roughly 15 more years. If he has a high-grade prostate cancer, that cancer can absolutely kill him within that window. The idea that prostate cancer is always a slow, harmless disease in older men is one of the most dangerous misconceptions in men's health.
The five-year survival rate for localised prostate cancer is close to 100 percent. For cancer that has spread to distant organs, it drops to around 30 percent. Early detection still saves lives in older men, which is why the decision to stop testing should be individual, not automatic.
The Overdiagnosis Problem Nobody Talks About Honestly
Here is the angle most articles on this topic miss. The argument against PSA screening after 70 is not really about the test itself. It is about what happens after a positive result.
When a PSA comes back elevated, the next step is usually a biopsy. Biopsies carry risks including infection, bleeding, and anxiety. If cancer is found, many men and their doctors feel compelled to treat it, even when watchful waiting would be the smarter choice. That treatment cascade, not the PSA test itself, is where the harm accumulates.
The medical system has historically been poor at helping men sit with a cancer diagnosis and do nothing. Active surveillance requires trust, discipline, and a doctor who is genuinely comfortable with monitoring rather than acting. When that infrastructure is not in place, a PSA test in an older man can set off a chain of interventions that leave him worse off than if he had never been tested.
This is the real reason behind the guideline. It is a system-level response to a system-level problem. For individual men with access to good urological care and a doctor who understands active surveillance, the calculus is different.
Why No PSA Test After 70 Is Not the Full Story
The phrase "why no PSA test after 70" frames this as a prohibition. It is not. It is a recommendation against routine, population-wide screening in an age group where the average benefit is outweighed by the average harm.
Average does not mean universal. A man who is 71, has no significant health conditions, has a family history of prostate cancer, and wants to be tested has every right to have that conversation with his GP. The guidelines support shared decision-making, not a hard cutoff.
What the evidence does not support is testing men who are already seriously ill, have a life expectancy under ten years, or who would not be candidates for treatment even if cancer were found. In those cases, a positive result creates anxiety and potential harm with no realistic path to benefit.
What to Ask Your Doctor Instead of Just Accepting the Answer
If your GP tells you PSA testing is not recommended at your age, these are the questions worth asking.
Ask whether your personal risk factors change the recommendation. Family history, ethnicity (men of African descent have higher prostate cancer rates), and previous PSA trends all matter.
Ask what your life expectancy is estimated to be. This sounds blunt, but it is the central variable in the decision. A man expected to live another 15 years has more to gain from early detection than one expected to live five.
Ask whether you would be a candidate for treatment if cancer were found. If the answer is no due to other health conditions, then testing has limited value. If the answer is yes, the conversation changes.
Ask about the difference between routine screening and diagnostic testing. If you have symptoms, a PSA test is not screening. It is part of a diagnostic workup, and the age guidelines do not apply in the same way.
FAQ
At what age should men stop getting PSA tests?
There is no single correct age. Most guidelines suggest that routine screening offers little benefit after 70 for the average man, but individual factors including health status, family history, and personal preference should drive the decision. Some men in their mid-seventies are good candidates for continued monitoring.
Can a PSA test detect cancer that has already spread?
A very high PSA level can suggest advanced disease, but imaging and biopsy are needed to confirm spread. PSA alone cannot tell you where the cancer is or how far it has progressed.
Is a PSA of 5 dangerous for a 70-year-old man?
A PSA of 5 sits in the grey zone and warrants further investigation, but it does not confirm cancer. A urologist would typically look at the trend over time, perform a digital rectal exam, and may recommend an MRI or biopsy depending on other risk factors.
Does a normal PSA mean no prostate cancer?
No. A small percentage of prostate cancers, including some aggressive ones, occur in men with PSA levels under 4.0 ng/mL. PSA is a useful screening tool but not a definitive test.
What is active surveillance and is it appropriate for older men?
Active surveillance means monitoring a low-risk prostate cancer with regular PSA tests, biopsies, and imaging rather than treating it immediately. It is often the right choice for older men with slow-growing tumours, and it avoids the side effects of surgery or radiation while keeping a close eye on whether the cancer changes.
The One Thing Worth Doing After Reading This
If you are over 70 and have not had a direct conversation with your GP about your personal prostate cancer risk, book that appointment. Do not accept a blanket answer in either direction. Ask about your specific history, your life expectancy, and whether the benefits of testing outweigh the risks for you as an individual. That conversation is the test that actually matters.
Does Bupa Cover Day Surgery in Australia? What You Actually Get
Read article →
What Is the 2 Week Rule for Prostate Cancer? A Clear Guide for Patients
Read article →
What Is the Prostate Pathway and How Does It Work?
Read article →
How to Check What Bupa Will Cover: A Clear Guide for Patients
Read article →
What Are the Exclusions for Bupa? What Your Policy Won't Cover
Read article →